Semaglutide is an expensive medication, so many people are wondering when it will go generic. Learn about the approximate generic release timeline for semaglutide.
Semaglutide is the active ingredient inside of the popular medications Ozempic, Wegovy, and Rybelsus. These medications are used for people with type 2 diabetes, or people who are trying to lose weight. And, they work pretty well for weight loss and blood glucose control. When used as prescribed, some people can lose up to about 15% of their body weight.
But, many people find the high cost of this medication to be a deterrent to using it. Since many people know that generic versions tend to be much cheaper, while also giving you the exact same active ingredients, the arrival of a generic Semaglutide medication is highly anticipated.
So, just when should you expect a generic Semaglutide medication to be available, what might the cost be of a generic Semaglutide, and what are some options to help make Semaglutide more affordable in the meantime? In this article, we will get you the answers to these questions.
There is currently no available FDA-approved generic for Semaglutide medications. Though a manufacturer, only the brand name medications Ozempic, Wegovy, and Rybelsus are currently available.
However, some compounding pharmacies are able to source the raw Semaglutide ingredient and make it into medications for use during the current drug shortage.
When a new medication comes on the market, the pharmaceutical companies that own the brand name medications are able to get exclusive patent rights for a number of years. During the times that these medications are under patent, there will not be an approved generic available.
It is not totally clear exactly when a Semaglutide generic will be available. But, some estimates according to the current Semaglutide patents may be in 2031 or later. Sometimes these timelines can be changed, which is why we don’t know for sure at this moment.
We don’t yet know what the cost of a generic Semaglutide medication might be. But, some sources suggest that it will be significantly lower than the brand-name pricing.
One Healthline article reported that Semaglutide might eventually be able to be manufactured for less than $5 a month. Potentially significantly reducing the price for patients. However, we will have to wait and see how the eventual generic pricing works out in the future.
Here at Strut Health, we don’t have the FDA-approved generic Semaglutide (since no one does, as it will be at least a few years until these come onto the market). But, we do offer Semaglutide compounds to help keep up with medication supply during the current Semaglutide shortage.
To learn more about our oral and injectable Semaglutide formulations, take a look at our Semaglutide product page today. To get started, simply select the product you are considering, and complete a questionnaire-based doctor’s consultation completely online.
.png)
.png){kind=icon}
.png){kind=icon}
